A detailed history of Teza Capital Management LLC transactions in Incyte Corp stock. As of the latest transaction made, Teza Capital Management LLC holds 50,678 shares of INCY stock, worth $3.42 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
50,678
Previous 41,918 20.9%
Holding current value
$3.42 Million
Previous $2.39 Million 28.64%
% of portfolio
0.38%
Previous 0.32%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$51.18 - $63.75 $448,336 - $558,450
8,760 Added 20.9%
50,678 $3.07 Million
Q1 2024

May 15, 2024

BUY
$56.55 - $66.59 $1.04 Million - $1.22 Million
18,305 Added 77.52%
41,918 $2.39 Million
Q4 2023

Feb 14, 2024

SELL
$52.16 - $64.19 $4.91 Million - $6.04 Million
-94,078 Reduced 79.94%
23,613 $1.48 Million
Q3 2023

Feb 22, 2024

BUY
$57.77 - $65.93 $2.39 Million - $2.73 Million
41,405 Added 124.31%
74,713 $4.32 Million
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $2.95 Million - $3.37 Million
51,075 Added 76.67%
117,691 $6.8 Million
Q2 2023

Feb 22, 2024

SELL
$60.95 - $75.51 $130,372 - $161,515
-2,139 Reduced 6.03%
33,308 $2.07 Million
Q2 2023

Aug 14, 2023

BUY
$60.95 - $75.51 $317,305 - $393,105
5,206 Added 8.48%
66,616 $4.15 Million
Q1 2023

Feb 22, 2024

BUY
$70.23 - $86.01 $831,101 - $1.02 Million
11,834 Added 50.12%
35,447 $2.56 Million
Q1 2023

May 15, 2023

BUY
$70.23 - $86.01 $4.31 Million - $5.28 Million
61,410 New
61,410 $4.44 Million
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $968,676 - $1.21 Million
14,637 New
14,637 $975,000
Q1 2022

May 16, 2022

SELL
$66.02 - $79.71 $250,611 - $302,579
-3,796 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$63.34 - $74.11 $198,760 - $232,557
-3,138 Reduced 45.26%
3,796 $279,000
Q3 2021

Nov 10, 2021

BUY
$68.67 - $84.02 $476,157 - $582,594
6,934 New
6,934 $477,000
Q2 2021

Aug 06, 2021

SELL
$79.87 - $87.53 $302,787 - $331,826
-3,791 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$76.02 - $100.5 $288,191 - $380,995
3,791 New
3,791 $308,000
Q2 2020

Aug 10, 2020

SELL
$74.18 - $108.93 $296,497 - $435,393
-3,997 Closed
0 $0
Q1 2020

May 11, 2020

SELL
$63.18 - $85.97 $490,466 - $667,385
-7,763 Reduced 66.01%
3,997 $293,000
Q4 2019

Feb 12, 2020

BUY
$73.04 - $95.72 $858,950 - $1.13 Million
11,760 New
11,760 $1.03 Million
Q3 2018

Nov 14, 2018

SELL
$61.75 - $74.23 $958,977 - $1.15 Million
-15,530 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$60.85 - $83.98 $945,000 - $1.3 Million
15,530 New
15,530 $1.04 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Teza Capital Management LLC Portfolio

Follow Teza Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teza Capital Management LLC with notifications on news.